BookAndrea Montalto, Antonio Loforte, Francesco Musumeci, Thomas Krabatsch, Mark S. Slaughter, editors ; in collaboration with Cristiano Amarelli.
Contents:
PART I: PREOPERATIVE EVALUATION
1 Physiopathology and Fate of End-Stage Cardiac Heart Failure in the era of Mechanical Circulatory Support
2 The Advantage of Mechanical Solution: Results of Clinical Trials to Date
3 Mechanical Circulatory Support Candidate Selection Criteria
4 Preoperative Assessment and Clinical Optimization
5 Preoperative Evaluation of Right Ventricular Function
6 High INTERMACS profiles: Medical vs. Mechanical Circulatory Support treatment
7 Low INTERMACS Profiles: which Strategies? (Temporary ECMO or TAH support; Temporary mid-term Paracorporeal Ventricular Assisted Device Support; Primary long-term Ventricular Assisted Device placement)
8 From BTT to DT Strategy: USA and Europe views
9 Mechanical Circulatory Support as a Bridge to Recovery
10 Mechanical Circulatory Support as a Bridge to Candidacy
PART II: INTRAOPERATIVE TIPS AND PITFALLS
11 Pulsatile vs. Continuous Flow pumps: Engineering and Clinical Considerations
12 Which Approach? Traditional vs. MICS
13 To Pump or not to Pump: the Role of Cardio-Pulmonary Bypass or ECMO
14 Techniques for Inflow Cannula Placement
15 Techniques for Outflow Cannula Placement
16 Techniques for Driveline Positioning
17 Percutaneous Devices: Options
18 Paracorporeal Biventricular Devices
19 Biventricular Implantable Continuous flow pumps
20 The Total Artificial Heart
21 Mechanical Circulatory Support in Pediatric Population
22 Concomitant Cardiac Surgery during Ventricular Assisted Device Placement: When is It too Much?
23 Pump Removal after Recovery
24 Intraoperative anesthesiological monitoring and management
25 Intraoperative right ventricular failure management
PART III: POSTOPERATIVE RECOMMENDATIONS
26 Physiotherapy and Rehabilitation Management in Ventricular Assisted Device Patients
27 Coagulation Monitoring
28 Adverse events management: Ischemic and Haemorragic Stroke
29 Adverse events management: Gastro-intestinal Bleeding
30 Adverse events management: Pump Thrombosis
31 Adverse events management: Infectious Complications
32 Adverse events management: AVW Syndrome
33 Adverse events management: Concomitant non-Cardiac Surgery during MCS: Management of Therapy
34 Pump and Equipment Failure: How to Behave
35 The Outpatient Care: The Role of Ventricular Assisted Device coordinator and the Remote Monitoring
PART IV: MISCELLANEA
36. Miniaturization and Future Technologies
37 ReliantHeart
Forward Compatibility and TET
38 The BIVACOR project
39 Potential of CARMAT in the Future
40 The ReinHeart Solution
41 Ethical and Psychological aspects of long-term MCS
42 Health-Economic Aspects of Mechanlical Circulatory Support Therapy
43 The Mechanical Circulatory Support Registries: Role and Perspectives
44 Conclusions.